Total submissions: 21
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172683 | SCV000051751 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040102 | SCV000063793 | benign | not specified | 2015-02-10 | criteria provided, single submitter | clinical testing | p.His8848Tyr in exon 104 of TTN: This variant is not expected to have clinical s ignificance because it has been identified in 1.1% (76/6614) of Finnish chromoso mes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; d bSNP rs72650011). |
Gene |
RCV000040102 | SCV000237054 | benign | not specified | 2016-08-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000040102 | SCV000249250 | uncertain significance | not specified | 2014-06-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081687 | SCV000286563 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000040102 | SCV000332661 | likely benign | not specified | 2015-07-02 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000172683 | SCV000884767 | benign | not provided | 2023-10-31 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768893 | SCV000900266 | benign | Cardiomyopathy | 2019-06-26 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000986941 | SCV001136100 | benign | Dilated cardiomyopathy 1G | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000172683 | SCV001153007 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | TTN: BS1 |
Illumina Laboratory Services, |
RCV000986941 | SCV001292873 | likely benign | Dilated cardiomyopathy 1G | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Athena Diagnostics | RCV000040102 | SCV001880239 | benign | not specified | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040102 | SCV002571015 | likely benign | not specified | 2022-07-30 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV000143966 | SCV000188847 | uncertain significance | Primary dilated cardiomyopathy | 2013-09-27 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000172683 | SCV001742617 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000172683 | SCV001799896 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040102 | SCV001923369 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000172683 | SCV001932983 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000040102 | SCV001953998 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000172683 | SCV001966658 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004534882 | SCV004749682 | likely benign | TTN-related disorder | 2020-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |